Arteriosclerosis, Vol 10, 727-731, Copyright © 1990 by American Heart Association

ARTICLES

Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?

SM Haffner, MP Stern, MK Gruber, HP Hazuda, BD Mitchell and JK Patterson
Department of Medicine, University of Texas Health Science Center, San Antonio 78284.

Microalbuminuria is associated with progression to renal disease in insulin-dependent diabetes and with increased mortality in noninsulin- dependent diabetes. In contrast, few studies have addressed the effect of microalbuminuria on cardiovascular risk in nondiabetics. We, therefore, determined the level of microalbuminuria in 316 nondiabetic subjects from the San Antonio Heart Study, a population-based study of diabetes and cardiovascular risk factors. Microalbuminuria (greater than or equal to 30 mg/l) was found in 42 of these 316 subjects (13%). Subjects with microalbuminuria had significantly higher blood pressure, triglyceride concentration, sum of insulin concentrations during a glucose tolerance test, and prevalence of hypertension and of self- reported myocardial infarction than subjects without microalbuminuria. When subjects with hypertension were excluded (n = 27), normotensive subjects with microalbuminuria (n = 31) still had significantly higher triglyceride concentrations and insulin sum than normotensive subjects without microalbuminuria (n = 258), suggesting that an increased atherogenic risk factor pattern exists even in normotensive subjects with microalbuminuria. Microalbuminuria may be a marker for cardiovascular risk, although it is not certain whether microalbuminuria causes these metabolic changes or results from some metabolic disturbance such as insulin resistance.

This article has been cited by other articles:

				R. P. Donahue, S. Stranges, K. Rejman, L. B. Rafalson, J. Dmochowski, and M. Trevisan Elevated Cystatin C Concentration and Progression to Pre-Diabetes: The Western New York Study Diabetes Care, July 1, 2007; 30(7): 1724 - 1729. [Abstract] [Full Text] [PDF]

				Z. Wang and W. E Hoy Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians Int. J. Epidemiol., October 1, 2006; 35(5): 1331 - 1335. [Abstract] [Full Text] [PDF]

				P. A. Sarafidis and G. L. Bakris Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2366 - 2374. [Full Text] [PDF]

				G. Montalescot and J.-P. Collet Preserving cardiac function in the hypertensive patient: why renal parameters hold the key Eur. Heart J., December 2, 2005; 26(24): 2616 - 2622. [Abstract] [Full Text] [PDF]

				I. F. Godsland, D. Crook, A. J. Proudler, and J. C. Stevenson Hemostatic Risk Factors and Insulin Sensitivity, Regional Body Fat Distribution, and the Metabolic Syndrome J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 190 - 197. [Abstract] [Full Text] [PDF]

				E. M. Stuveling, S. J.L. Bakker, H. L. Hillege, J. G.M. Burgerhof, P. E. de Jong, R. O.B. Gans, D. de Zeeuw, and for the PREVEND Study Group C-Reactive Protein Modifies the Relationship Between Blood Pressure and Microalbuminuria Hypertension, April 1, 2004; 43(4): 791 - 796. [Abstract] [Full Text] [PDF]

				J. T. Lane Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective Am J Physiol Renal Physiol, March 1, 2004; 286(3): F442 - F450. [Abstract] [Full Text] [PDF]

				D. R. Jacobs Jr., M. A. Murtaugh, M. Steffes, X. Yu, J. Roseman, and F. C. Goetz Gender- and Race-specific Determination of Albumin Excretion Rate using Albumin-to-Creatinine Ratio in Single, Untimed Urine Specimens:The Coronary Artery Risk Development in Young Adults Study Am. J. Epidemiol., June 15, 2002; 155(12): 1114 - 1119. [Abstract] [Full Text] [PDF]

				C. M. Hoehner, K. J. Greenlund, S. Rith-Najarian, M. L. Casper, and W. M. McClellan Association of the Insulin Resistance Syndrome and Microalbuminuria among Nondiabetic Native Americans.The Inter-Tribal Heart Project J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1626 - 1634. [Abstract] [Full Text] [PDF]

				G. F.H. Diercks, E. S.G. Stroes, A. J. van Boven, A. M. van Roon, H. L. Hillege, P. E. de Jong, A. J. Smit, R. O.B. Gans, H. J.G.M. Crijns, T. J. Rabelink, et al. Difference in the Relation Between Urinary Albumin Excretion and Carotid Intima-Media Thickness in Nondiabetic and Type 2 Diabetic Subjects Diabetes Care, May 1, 2002; 25(5): 936 - 937. [Full Text]

				R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vascular Medicine, November 1, 2001; 6(4): 257 - 264. [Abstract] [PDF]

				R. C.P. Go, R. Desmond, J. M. Roseman, D. S.H. Bell, C. Vanichanan, and R. T. Acton Prevalence and Risk Factors of Microalbuminuria in a Cohort of African-American Women With Gestational Diabetes Diabetes Care, October 1, 2001; 24(10): 1764 - 1769. [Abstract] [Full Text] [PDF]

				A Varghese, R Deepa, M Rema, and V Mohan Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India Postgrad. Med. J., June 1, 2001; 77(908): 399 - 402. [Abstract] [Full Text]

				G.F.H Diercks, A.J van Boven, H.L Hillege, W.M.T Janssen, J.A Kors, P.E de Jong, D.E Grobbee, H.J.G.M Crijns, and W.H van Gilst Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study Eur. Heart J., December 1, 2000; 21(23): 1922 - 1927. [Abstract] [PDF]

				S.-J. PINTO-SIETSMA, W. M.T. JANSSEN, H. L. HILLEGE, G. NAVIS, D. D. ZEEUW, and P. E. D. JONG Urinary Albumin Excretion Is Associated with Renal Functional Abnormalities in a Nondiabetic Population J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1882 - 1888. [Abstract] [Full Text]

				R. J. Hogg, R. J. Portman, D. Milliner, K. V. Lemley, A. Eddy, and J. Ingelfinger Evaluation and Management of Proteinuria and Nephrotic Syndrome in Children: Recommendations From a Pediatric Nephrology Panel Established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE) Pediatrics, June 1, 2000; 105(6): 1242 - 1249. [Abstract] [Full Text]

				K. Borch-Johnsen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and J. S. Jensen Urinary Albumin Excretion : An Independent Predictor of Ischemic Heart Disease Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1992 - 1997. [Abstract] [Full Text] [PDF]

				P. Clausen, J. S. Jensen, K. Borch-Johnsen, G. Jensen, and B. Feldt-Rasmussen Ambulatory Blood Pressure and Urinary Albumin Excretion in Clinically Healthy Subjects Hypertension, July 1, 1998; 32(1): 71 - 77. [Abstract] [Full Text] [PDF]

				M. A. Kessler, A. Meinitzer, W. Petek, and O. S. Wolfbeis Microalbuminuria and borderline-increased albumin excretion determined with a centrifugal analyzer and the Albumin Blue 580 fluorescence assay Clin. Chem., June 1, 1997; 43(6): 996 - 1002. [Abstract] [Full Text] [PDF]

				K. Kario, N. Kanai, S. Nishiuma, T. Fujii, K. Saito, T. Matsuo, M. Matsuo, and K. Shimada Hypertensive Nephropathy and the Gene for Angiotensin-Converting Enzyme Arterioscler Thromb Vasc Biol, February 1, 1997; 17(2): 252 - 256. [Abstract] [Full Text]

				S. Agewall and B. Fagerberg Risk Factors That Predict Development of Microalbuminuria in Treated Hypertensive Men Angiology, October 1, 1996; 47(10): 963 - 972. [Abstract] [PDF]

				K. Kario, T. Matsuo, H. Kobayashi, M. Matsuo, T. Sakata, T. Miyata, and K. Shimada Factor VII Hyperactivity and Endothelial Cell Damage Are Found in Elderly Hypertensives Only When Concomitant With Microalbuminuria Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 455 - 461. [Abstract] [Full Text]

				S. Bianchi, R. Bigazzi, A. Q. Galvan, E. Muscelli, G. Baldari, N. Pecori, D. Ciociaro, E. Ferrannini, and A. Natali Insulin Resistance in Microalbuminuric Hypertension : Sites and Mechanisms Hypertension, November 1, 1995; 26(5): 789 - 795. [Abstract] [Full Text]

				W.-J. Foyle, E. Carstensen, M. C. Fernandez, and J. S. Yudkin Longitudinal Study of Associations of Microalbuminuria With the Insulin Resistance Syndrome and Sodium-Lithium Countertransport in Nondiabetic Subjects Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1330 - 1337. [Abstract] [Full Text]

				K. Kario, T. Matsuo, H. Kobayashi, M. Matsuo, T. Sakata, and T. Miyata Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With Microalbuminuria Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1114 - 1120. [Abstract] [Full Text]

				O. Giampietro, E. Matteucci, G. Catapano, G. Dell'Omo, L. Talarico, C. Di Muro, V. Di Bello, and R. Pedrinelli Microalbuminuria and Erythrocyte Sodium-Hydrogen Exchange in Essential Hypertension Hypertension, May 1, 1995; 25(5): 981 - 985. [Abstract] [Full Text]

				J. Kuusisto, L. Mykkanen, K. Pyorala, and M. Laakso Hyperinsulinemic Microalbuminuria : A New Risk Indicator for Coronary Heart Disease Circulation, February 1, 1995; 91(3): 831 - 837. [Abstract] [Full Text]